精神科門診憂鬱症病人之處遇模式與治療配合度

Treatment Modality and Compliance in Depressive Outpatients

10.29478/TJP.200706.0005

周勵志(Lih-Chin Jou)；鄭舒方(Shu-Fang Cheng)

憂鬱症 ； 治療配合度 ； 回診穩定度 ； 服藥規則度 ； depressive disorder ； medical compliance ； stability of revisiting ； treatment regularity

台灣精神醫學

21卷2期（2007 / 06 / 01）

107 - 116

繁體中文

Objective: The aim of this study was to discuss the influence and interaction between treatment modality and compliance, and depression severity. Method: Forty-nine depressive outpatients completed at least 6-month follow up among initial 123 patients recruited for this study. Purposive sampling was used to divide the subjects into two groups based on medication as follows: treat as usual (TAU) and combined therapy (CT). The investigative instruments were the Beck Depress-ion Inventory, the Brief Symptom Rating Scale and a questionnaire exploring clinical characteristics and patient compliance during follow up. Scheduled follow up was at least 6 months in each case. Results: Forty percent of the patient completed follow up with completion rates of 67% and 23% for the CT and TAU groups, respectively. After the 6-month follow up, symptom improvement of the former group was more significant compared to the latter despite the greater dosing regularity in the TAU group (X^2=4.07, df=1, p＜.05), with the difference already evident after the first month of treatment (T=3.23, df=30, p＜.05). There was an inverse relationship between treatment regularity and depression severity. (X^2=9.27, df=3, p＜.05) Treatment regularity (F=6.30, df=1, p＜.05) and the interaction between the stability of OPD revisiting and depression severity (F=5.54, df=1, p＜.05). Conclusion: In this study, the combined treatment was associated with greater willingness for OPD revisiting at the beginning of follow up, with depression severity and the compliance also subsequently improved. Moreover, depression severity and the treatment regularity also directly influenced symptom improvement.

Objective: The aim of this study was to discuss the influence and interaction between treatment modality and compliance, and depression severity. Method: Forty-nine depressive outpatients completed at least 6-month follow up among initial 123 patients recruited for this study. Purposive sampling was used to divide the subjects into two groups based on medication as follows: treat as usual (TAU) and combined therapy (CT). The investigative instruments were the Beck Depress-ion Inventory, the Brief Symptom Rating Scale and a questionnaire exploring clinical characteristics and patient compliance during follow up. Scheduled follow up was at least 6 months in each case. Results: Forty percent of the patient completed follow up with completion rates of 67% and 23% for the CT and TAU groups, respectively. After the 6-month follow up, symptom improvement of the former group was more significant compared to the latter despite the greater dosing regularity in the TAU group (X^2=4.07, df=1, p＜.05), with the difference already evident after the first month of treatment (T=3.23, df=30, p＜.05). There was an inverse relationship between treatment regularity and depression severity. (X^2=9.27, df=3, p＜.05) Treatment regularity (F=6.30, df=1, p＜.05) and the interaction between the stability of OPD revisiting and depression severity (F=5.54, df=1, p＜.05). Conclusion: In this study, the combined treatment was associated with greater willingness for OPD revisiting at the beginning of follow up, with depression severity and the compliance also subsequently improved. Moreover, depression severity and the treatment regularity also directly influenced symptom improvement.

1. Beck AT, Steer RA, Brown GK 陳心怡翻譯：貝克憂鬱量表第二版（中文版）。台北市：中國行為科學社股份有限公司，1990；15-26。
2. Bond, M(2006).Psychodynamic psychotherapy in the treatment of mood disorders.Curr Opin Psychiatry,19,40-3.
3. de Jonghe, F,Hendricksen, M,van Aalst, G(2004).Psychotherapy alone and combined with pharmacotherapy in the treatment of depression.Br J Psychiatry,185,37-45.
4. Katzelnick, DJ,Simon, GE,Pearson, SD(2000).Randomized Trial of a Depression Management Program in High Utilizers of Medical Care.Arch Fam Med,9,345-51.
5. Kessler, RC,McGonagle, KA,Zhao, S(1994).Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey.Arch Gen Psychiatry,51(1),8-19.
6. Lee, MB,Lee, YJ,Yen, LL(1990).Reliability and validity of using a Brief Psychiatric Symptom Rating Scale in Clinical Practice.J Formosan Med Assoc,1081-7.
7. Markowitz, JC,Kocsis, JH,Bleiberg, KL(2005).A comparative trial of psychotherapy and pharmacotherapy for "pure" dysthymic patients.J Affect Disord,89,167-75.
8. Melfi, CA,Chawla, AJ,Croghan, TW,Hanna, MP,Kennedy, S,Sredl, K(1998).The effects of adherence to antidepressant treatment guidelines on relapse and recurrence of depression.Arch Gen Psychiatry,55,1128-32.
9. Sandro, P,Paola, B,Giuseppe, T(2004).Combined-pharmacotherapy and psychological treatment for depression: a systematic review.Arch Gen Psychiatry,61,714-9.
10. Thase, ME,Greenhouse, JB,Frank, E(1997).Treatment of major depression with psychotherapy or psychotherapy-pharmacotherapy combinations.Arch Gen Psychiatry,54,1009-15.
11. 林信男(2002)。憂鬱症的生物性治療。學生輔導，80，60-7。
12. 莊美華、王昱豐、林俊龍、李紀慧(2004)。門診藥局對慢性疾病病患藥品使用後續追蹤評估。慈濟醫學，16，173-83。
13. 廖士程、吳佳璇(2003)。憂鬱症之診斷與治療。台大醫網，14，16-8。

1. Wang, Wen-Fu,Liao, Yi-Cheng,Lai, Te-Jen,Huang, Si-Sheng(2012).The Factors Associated with Burden of Caring Patients with Dementia: A Memory Clinic Based Study.台灣精神醫學,26(2),96-104.